首页|盐酸氨溴索溶液改善儿童支气管炎黏痰症状的研究

盐酸氨溴索溶液改善儿童支气管炎黏痰症状的研究

扫码查看
目的 评价吸入用盐酸氨溴索溶液改善儿童支气管炎黏痰症状的有效性及安全性.方法 纳入2021年4月至2022年4月全国46家中心的急性支气管炎患儿491例,均雾化吸入用盐酸氨溴索溶液治疗7 d.观察并比较治疗前后咳嗽、喉中痰鸣及肺部听诊评分变化情况,分析咳嗽、喉中痰鸣及肺部听诊的改善率及临床应答率.结果 治疗后,患儿咳嗽、喉中痰鸣、肺部听诊改善率及临床应答率分别为96.33%、88.59%、76.17%及93.69%.咳嗽症状评分、喉中痰鸣评分及肺部听诊评分均随用药时间延长而显著降低,用药前后各评分差异显著(P<0.05).疾病亚组分析显示,无论支气管炎疾病类型、有无过敏史,组间临床有效性无显著差异(P>0.05).结论 吸入用盐酸氨溴索溶液可有效改善儿童支气管炎呼吸道症状及体征,安全性良好.
A study on improvement of phlegm symptoms of bronchitis in children by ambroxol hydrochloride solution
Objective To evaluate the efficacy and safety of inhaled ambroxol hydrochloride solution in improving the phlegm symptoms of bronchitis in children.Methods A total of 491 children with acute bronchitis from 46 centers in China from April 2021 to April 2022 were included and treated with atomized ambroxol hydrochloride solution for 7 days.The changes of cough score,laryngeal phlegm cry score and pulmonary auscultation score before and after treatment were observed and compared,and the improvement rate and clinical response rate of cough,laryngeal phlegm cry score and pulmonary auscultation score were analyzed.Results After treatment,the improvement rates of cough,phlegm in larynx,lung auscultation and the clinical response rate were 96.33%,88.59%,76.17%and 93.69%,respectively.Cough symptom score,laryngeal phlegm singing score and pulmonary auscultation score were significantly decreased with the extension of medication time,and the scores were significantly different before and after medication(P<0.05).Disease subgroup analysis showed no significant difference in clinical effectiveness between groups regardless of bronchitis disease type or the history of allergies(P>0.05).Conclusion Inhaled ambroxol hydrochloride solution can effectively improve the respiratory symptoms and signs of bronchitis in children with good safety.

ambroxol hydrochloride solution for inhalationacute bronchitisasthmatic bronchitisphlegm symptom

王昊、徐保平、国家呼吸系统疾病临床医学研究中心及协同单位

展开 >

国家儿童医学中心,国家呼吸系统疾病临床研究中心,首都医科大学附属北京儿童医院呼吸科,北京 100045

吸入用盐酸氨溴索溶液 急性支气管炎 喘息性支气管炎 黏痰症状

2024

世界临床药物
上海医药工业研究院

世界临床药物

CSTPCD
影响因子:0.849
ISSN:1672-9188
年,卷(期):2024.45(8)
  • 11